Sensei Biotherapeutics Inc Strategic Asset Allocation Index
Sensei Biotherapeutics Inc strategic asset allocation index. Sensei Biotherapeutics Inc (SNSE) has a Strategic Asset Allocation Index of 10.6% as of June 2023. Strategic assets (PP&E of $8.43 Million plus long-term investments of $-) total $8.43 Million, measured against net assets of $79.20 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See SNSE equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Sensei Biotherapeutics Inc (2020–2021)
Strategic asset allocation index of Sensei Biotherapeutics Inc from 2020 to 2021. This chart shows how Sensei Biotherapeutics Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of June 2023, the index stands at 10.6%, representing strategic assets of $8.43 Million against net assets of $79.20 Million USD. Check SNSE intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Sensei Biotherapeutics Inc Strategic Asset Allocation Index by Year (2020–2021)
Sensei Biotherapeutics Inc strategic asset allocation index by year from 2020 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Sensei Biotherapeutics Inc from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Sensei Biotherapeutics Inc (SNSE) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 3.2% | $4.64 Million | $4.64 Million | $- | $146.51 Million | ▼ -4.8 pp |
| 2020 | 8.0% | $1.27 Million | $1.27 Million | $- | $15.89 Million | — |